Lapatinib for Brain Metastases In ErbB2-Positive Breast Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT00263588
Recruitment Status : Active, not recruiting
First Posted : December 9, 2005
Last Update Posted : February 21, 2018
Information provided by (Responsible Party):
Novartis ( Novartis Pharmaceuticals )